Use of EDG receptor binding agents in cancer

Details for Australian Patent Application No. 2003240655 (hide)

Owner Novartis AG

Inventors Brinkmann, Volker; Baumruker, Thomas; Lassota, Peter T.; Mechtcheriakova, Diana; La Montagne, Kenneth Richard; Wood, Jeanette Marjorie

Agent Davies Collison Cave

Pub. Number AU-B-2003240655

PCT Number PCT/EP03/05125

PCT Pub. Number WO2003/097028

Priority 0217150.2 24.07.02 GB; 0211261.3 16.05.02 GB; 60/449,739 24.02.03 US; 60/390,411 20.06.02 US

Filing date 15 May 2003

Wipo publication date 2 December 2003

Acceptance publication date 6 September 2007

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/661 (2006.01) - Phosphorus acids or esters thereof not having PC bonds, e.g. fosfosal, dichlorvos, malathion

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 0217150.2 24.07.02 GB; 0211261.3 16.05.02 GB; 60/449,739 24.02.03 US; 60/390,411 20.06.02 US

29 January 2004 Application Open to Public Inspection

  Published as AU-B-2003240655

6 September 2007 Application Accepted

  Published as AU-B-2003240655

10 January 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003240656-Method for the production of sulphamic acid halogenides

2003240654-PHARMACEUTICAL COMPOSITION CONTAINING OXCARBAZEPINE AND HAVING A CONTROLLED ACTIVE SUBSTANCE RELEASE